Form 4: Macrogenics Director Meenu Chhabra Reports Stock Transactions

Director Meenu Chhabra reports acquisition and disposal of Macrogenics Inc. stock and derivative securities.

Summary

• On May 20, 2025, Director Meenu Chhabra reported transactions involving Macrogenics Inc. (MGNX) securities.
• Chhabra acquired 6,500 shares of common stock through the vesting of restricted stock units (RSUs) and disposed of the same amount.
• Following the reported transactions, Chhabra directly owns 11,000 shares of Macrogenics common stock.
• Chhabra also acquired 3,750 RSUs that will vest one year after the grant date or the day prior to the next annual meeting, if earlier.
• Additionally, Chhabra acquired options to buy 22,000 and 49,213 shares of common stock at an exercise price of $1.49 and $1.27 respectively, which vest in monthly increments starting one month from the grant date and expire on May 21, 2035.
• The option grant for 49,213 shares is in lieu of direct cash compensation for the director's annual retainer.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing of stock transactions by a company director. The acquisition of stock options and RSUs could be seen as a slightly positive sign, indicating confidence in the company, but it's not a major event.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
• The vesting of RSUs demonstrates the director's continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the vesting schedules of the RSUs and stock options suggest a continued relationship between the director and the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Comparison to Industry Standards

• Director compensation packages often include a mix of salary, stock options, and restricted stock units (RSUs).
• The vesting schedules and exercise prices of these instruments are typically designed to align the interests of management with those of shareholders.
• The specifics of these packages vary widely across companies and industries, depending on factors such as company size, performance, and industry norms.
• Comparing Macrogenics' director compensation practices to those of its peers would require a more detailed analysis of its compensation policies and practices.

Stakeholder Impact

• The transactions reported in the Form 4 filing provide transparency to shareholders regarding the director's holdings and transactions in the company's stock.
• The vesting of RSUs and stock options aligns the director's interests with those of shareholders, incentivizing them to work towards the company's success.

Key Dates

Keywords

Macrogenics, MGNX, Form 4, Director, Meenu Chhabra, Stock Options, RSU, Securities, Beneficial Ownership